Stampacchia Otello

FollowCreate a free account to set a filing alert.

10% owner at Lexeo Therapeutics, Inc. · on record since Nov 9, 2023
Director at MICROMET, INC. · on record since May 9, 2006
10% owner at MICROMET, INC. · on record since May 9, 2006
10% owner at WAVETRUE, INC. · on record since Nov 10, 2014
10% owner at Precipio, Inc. · on record since Jun 27, 2018
Former 10% Owner at Kezar Life Sciences, Inc. · on record since Jun 25, 2018
10% owner at Kezar Life Sciences, Inc. · on record since Jun 20, 2018
Director at Replimune Group, Inc. · on record since Jul 25, 2018
10% owner at Replimune Group, Inc. · on record since Jul 25, 2018
Director at Gossamer Bio, Inc. · on record since Feb 12, 2019
10% owner at Gossamer Bio, Inc. · on record since Feb 12, 2019
Director at Morphic Holding, Inc. · on record since Jun 26, 2019
10% owner at Morphic Holding, Inc. · on record since Jun 26, 2019
10% owner at IMMUNIC, INC. · on record since Apr 22, 2019
Director at Omega Alpha SPAC · on record since Jan 13, 2021
Chief Executive Officer at Omega Alpha SPAC · on record since Jan 13, 2021
10% owner at Omega Alpha SPAC · on record since Jan 13, 2021
10% owner at Panacea Acquisition Corp. II · on record since Feb 12, 2021
Former 10% owner at · on record since Oct 14, 2021
10% owner at · on record since Oct 6, 2021
Director at · on record since Mar 25, 2021
Director at · on record since Oct 16, 2020
10% owner at · on record since Oct 16, 2020

Insider trading activity of Stampacchia Otello

Transactions on record: 181; since May 9, 2006

Purchases: 5; $26.6M

Sales: 142; $46.3M

Companies traded: 7; last filing Jun 18, 2026

Figures computed from official regulatory filings — .

Companies where Stampacchia Otello has traded

12 tx · $33.2M · Jun 18, 2026
9 tx · $14.5M · Jun 29, 2022
5 tx · $3.9M · Sep 27, 2021
92 tx · $25.8M · Apr 15, 2021
1 tx · $5M · Jan 13, 2021
7 tx · $2.4M · Sep 12, 2019
55 tx · $19.2M · Mar 4, 2010

Track record of Stampacchia Otello

Statistical track record

Free account

Purchases: 5

Last buy: Jul 25, 2025

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Stampacchia Otello

Co-insiders of Stampacchia Otello

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
ImageneBio, Inc.Listing unverified	Jun 18, 2026	AwardD (derivative)	15,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ImageneBio, Inc.Listing unverified	Jul 30, 2025	Exercise	379	—	n/a (No price was disclosed in the filing)		SEC
ImageneBio, Inc.Listing unverified	Jul 30, 2025	ExerciseD (derivative)	-17,520	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ImageneBio, Inc.Listing unverified	Jul 30, 2025	Buy	267,556	29.90 USD	$8M	conv 74First in 12mo	SEC
ImageneBio, Inc.Listing unverified	Jun 10, 2024	AwardD (derivative)	17,520	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ImageneBio, Inc.Listing unverified	Jun 13, 2023	AwardD (derivative)	17,520	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kronos Bio, Inc.Listing unverified	Jun 29, 2022	AwardD (derivative)	34,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ImageneBio, Inc.Listing unverified	Jun 13, 2022	AwardD (derivative)	13,419	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ImageneBio, Inc.Listing unverified	Dec 23, 2021	AwardD (derivative)	13,419	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Replimune Group, Inc.Listing on record	Sep 27, 2021	Sell	-12,171	33.58 USD	$408.7K		SEC
Kronos Bio, Inc.Listing unverified	Jun 23, 2021	AwardD (derivative)	20,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Morphic Holding, Inc.Listing unverified	Apr 15, 2021	Sell	-4,064	58.95 USD	$239.6K		SEC
Morphic Holding, Inc.Listing unverified	Apr 15, 2021	Sell	-4,097	55.88 USD	$228.9K		SEC
Morphic Holding, Inc.Listing unverified	Apr 15, 2021	Sell	-2,055	56.95 USD	$117K		SEC
Morphic Holding, Inc.Listing unverified	Apr 15, 2021	Sell	-1,758	56.70 USD	$99.7K		SEC
Morphic Holding, Inc.Listing unverified	Apr 15, 2021	Sell	-367	58.25 USD	$21.4K		SEC
Morphic Holding, Inc.Listing unverified	Apr 15, 2021	Sell	-4,879	57.61 USD	$281.1K		SEC
Morphic Holding, Inc.Listing unverified	Apr 15, 2021	Sell	-3,716	58.08 USD	$215.8K		SEC
Morphic Holding, Inc.Listing unverified	Apr 2, 2021	Sell	-112	63.97 USD	$7.2K		SEC
Morphic Holding, Inc.Listing unverified	Apr 2, 2021	Sell	-11,560	63.34 USD	$732.2K	Unusual size	SEC
Morphic Holding, Inc.Listing unverified	Apr 2, 2021	Sell	-2,064	64.44 USD	$133K		SEC
Morphic Holding, Inc.Listing unverified	Apr 2, 2021	Sell	-5,112	62.45 USD	$319.2K		SEC
Morphic Holding, Inc.Listing unverified	Apr 2, 2021	Sell	-1,312	66.01 USD	$86.6K		SEC
Morphic Holding, Inc.Listing unverified	Apr 2, 2021	Sell	-942	62.89 USD	$59.2K		SEC
Morphic Holding, Inc.Listing unverified	Apr 2, 2021	Sell	-9,303	65.19 USD	$606.5K		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
ImageneBio, Inc.Listing unverified	Jun 18, 2026	AwardD (derivative)	15,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ImageneBio, Inc.Listing unverified	Jul 30, 2025	Exercise	379	—	n/a (No price was disclosed in the filing)		SEC
ImageneBio, Inc.Listing unverified	Jul 30, 2025	ExerciseD (derivative)	-17,520	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ImageneBio, Inc.Listing unverified	Jul 30, 2025	Buy	267,556	29.90 USD	$8M	conv 74First in 12mo	SEC
ImageneBio, Inc.Listing unverified	Jun 10, 2024	AwardD (derivative)	17,520	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ImageneBio, Inc.Listing unverified	Jun 13, 2023	AwardD (derivative)	17,520	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kronos Bio, Inc.Listing unverified	Jun 29, 2022	AwardD (derivative)	34,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ImageneBio, Inc.Listing unverified	Jun 13, 2022	AwardD (derivative)	13,419	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ImageneBio, Inc.Listing unverified	Dec 23, 2021	AwardD (derivative)	13,419	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Replimune Group, Inc.Listing on record	Sep 27, 2021	Sell	-12,171	33.58 USD	$408.7K		SEC
Kronos Bio, Inc.Listing unverified	Jun 23, 2021	AwardD (derivative)	20,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Morphic Holding, Inc.Listing unverified	Apr 15, 2021	Sell	-4,064	58.95 USD	$239.6K		SEC
Morphic Holding, Inc.Listing unverified	Apr 15, 2021	Sell	-4,097	55.88 USD	$228.9K		SEC
Morphic Holding, Inc.Listing unverified	Apr 15, 2021	Sell	-2,055	56.95 USD	$117K		SEC
Morphic Holding, Inc.Listing unverified	Apr 15, 2021	Sell	-1,758	56.70 USD	$99.7K		SEC
Morphic Holding, Inc.Listing unverified	Apr 15, 2021	Sell	-367	58.25 USD	$21.4K		SEC
Morphic Holding, Inc.Listing unverified	Apr 15, 2021	Sell	-4,879	57.61 USD	$281.1K		SEC
Morphic Holding, Inc.Listing unverified	Apr 15, 2021	Sell	-3,716	58.08 USD	$215.8K		SEC
Morphic Holding, Inc.Listing unverified	Apr 2, 2021	Sell	-112	63.97 USD	$7.2K		SEC
Morphic Holding, Inc.Listing unverified	Apr 2, 2021	Sell	-11,560	63.34 USD	$732.2K	Unusual size	SEC
Morphic Holding, Inc.Listing unverified	Apr 2, 2021	Sell	-2,064	64.44 USD	$133K		SEC
Morphic Holding, Inc.Listing unverified	Apr 2, 2021	Sell	-5,112	62.45 USD	$319.2K		SEC
Morphic Holding, Inc.Listing unverified	Apr 2, 2021	Sell	-1,312	66.01 USD	$86.6K		SEC
Morphic Holding, Inc.Listing unverified	Apr 2, 2021	Sell	-942	62.89 USD	$59.2K		SEC
Morphic Holding, Inc.Listing unverified	Apr 2, 2021	Sell	-9,303	65.19 USD	$606.5K		SEC